Description |
Product Type |
Product Size |
Syrup |
1'S |
Product Company |
Highnoon Lab |
Sucralfate 120ml
|
Product Type |
Product Size |
Capsules |
14'S |
Product Company |
Searle Iv SOLN |
Omeprazole 20mg |
Product Type |
Product Size |
Tablet |
600'S |
Product Company |
Pfizer |
Mefenamic acid 250mg |
Product Type |
Product Size |
Syrup |
1'S |
Product Company |
ICI Pakistan |
Oxethazine with alumium hydroxide and magnesium hydroxide
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Carboplatin 150mg/15ml |
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Pfizer |
Amlodipine besylate 5mg
|
Content | " Sucralfate is a gastro-duodenal protective agent used in the treatment of gastric and duodenal ulcers and to prevent duodenal ulcer recurrence. "
| Omeprazole is used to treat frequent heartburn (heartburn that occurs at least 2 or more days a week) in adults. Omeprazole is in a class of medications called proton-pump inhibitors. | Mefenamic acid is used for the short-term relief of mild to moderate pain from various conditions such as headache, dental pain, menstrual cramps, and muscle aches.Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. | Oxetacaine is available as an over-the-counter antacid and it is used to alleviate pain associated with gastritis, peptic ulcer disease, heartburn, esophagitis. | Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
| Amlodipine is an oral antihypertensive medicine that belongs to the class of calcium channel blockers. It works by relaxing the blood vessels to allow easy flow of blood
|
Reviews
There are no reviews yet.